Jan 02, 2024
1:240
For every 240 shares held, investors received 1. The price per share adjusted from $0.00 to $0.04.
The split itself did not change the total investment value.
Avalo Therapeutics, Inc. (GETTEX:C6K0) operates in the Pharmaceuticals: major industry.
Avalo Therapeutics, Inc. company overviewAvalo Therapeutics, Inc.'s most recent stock split was on January 2, 2024. It was a 1-for-240 reverse split, so shareholders received 1 share for every 240 they held.
Avalo Therapeutics, Inc. (GETTEX:C6K0) has split its stock 2 times: a 1-for-12 reverse split on July 8, 2022 and a 1-for-240 reverse split on January 2, 2024.
Avalo Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between July 8, 2022 and January 2, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Avalo Therapeutics, Inc.'s 1-for-240 reverse split on January 2, 2024, every 240 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Avalo Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on January 2, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:C6K0 split will appear on this page.